While no comparable data are available for T2DM patients, studies on other populations, such as diabetic patients undergoing carotid endarterectomy, Eilenberg et al. [71] have shown that metformin reduces inflammatory state through the reduction of NGAL serum levels, and thus lowers the risk of cerebral embolic events. Here, LCN2 is linked to type 2 diabetes mellitus.